Neonatal Gene Therapy With a Gamma Retroviral Vector in Mucopolysaccharidosis VI Cats-Reference-Cited by-同舟云学术

Neonatal Gene Therapy With a Gamma Retroviral Vector in Mucopolysaccharidosis VI Cats

Published:2012-05 Issue:5 Volume:20 Page:898-907
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Ponder Katherine P,O'Malley Thomas M,Wang Ping,O'Donnell Patricia A,Traas Anne M,Knox Van W,Aguirre Gustavo A,Ellinwood N Matthew,Metcalf Jason A,Wang Bin,Parkinson-Lawrence Emma J,Sleeper Meg M,Brooks Doug A,Hopwood John J,Haskins Mark E

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference50 articles.

1. The Mucopolysaccharidoses;Neufeld,2001

2. Prevalence of lysosomal storage disorders;Meikle;JAMA,1999

3. Clinical and biochemical study of 28 patients with mucopolysaccharidosis type VI;Azevedo;Clin Genet,2004

4. Valvular heart disease in four patients with Maroteaux-Lamy syndrome;Tan;Circulation,1992

5. The natural course and the impact of therapies of cardiac involvement in the mucopolysaccharidoses;Fesslová;Cardiol Young,2009

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mucopolysaccharidosis Type VI, an Updated Overview of the Disease;International Journal of Molecular Sciences;2021-12-15

2. Cardiac pathology in mucopolysaccharidosis I mice: Losartan modifies ERK1 /2 activation during cardiac remodeling;Journal of Inherited Metabolic Disease;2020-11-10

3. Effects of gene therapy on cardiovascular symptoms of lysosomal storage diseases;Genetics and Molecular Biology;2019

4. Treatment of brain disease in the mucopolysaccharidoses;Molecular Genetics and Metabolism;2017-12

5. Mucopolysaccharidosis VI pathophysiology diagnosis and treatment;Frontiers in Bioscience;2017